Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiora Pharmaceuticals (KPRX) Return on Capital Employed (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Return on Capital Employed for 10 consecutive years, with 0.29% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.29%, compared with a TTM value of 0.29% through Sep 2025, changed N/A, and an annual FY2024 reading of 0.24%, changed N/A over the prior year.
  • Return on Capital Employed was 0.29% for Q3 2025 at Kiora Pharmaceuticals, down from 0.14% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.14% in Q4 2024 and bottomed at 1.66% in Q4 2021.
  • Average Return on Capital Employed over 5 years is 0.76%, with a median of 0.88% recorded in 2023.
  • The sharpest move saw Return on Capital Employed crashed -101bps in 2021, then skyrocketed 124bps in 2024.
  • Year by year, Return on Capital Employed stood at 1.66% in 2021, then rose by 29bps to 1.18% in 2022, then increased by 7bps to 1.1% in 2023, then skyrocketed by 113bps to 0.14% in 2024, then plummeted by -299bps to 0.29% in 2025.
  • Business Quant data shows Return on Capital Employed for KPRX at 0.29% in Q3 2025, 0.14% in Q4 2024, and 0.09% in Q1 2024.